The present invention relates to compounds of formula I:
or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.
The present invention relates to compounds of formula I:
or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.
[EN] AZABICYCLE DERIVATIVES AND PREPARATION METHOD AND USE THEREOF<br/>[FR] DÉRIVÉS D'AZABICYCLE, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION<br/>[ZH] 氮杂双环衍生物及其制备方法和用途
申请人:SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD